Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP) while Ozempic (Semaglutide) only targets GLP-1.

Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price lowered by Scotiabank from $105.00 to $80.00 in a ...

Analysts at StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical ...

PHARMACEUTICAL company Indies Pharma Jamaica Limited has secured US$405,000 or just over $60 million in its first drawdown ...

The document outlines various health-related news, including a measles outbreak in Texas and New Mexico, UNICEF's aid crisis ...

Researchers at Indiana University and Wuhan University in China have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building ...

Coalition trade spokesman Kevin Hogan said the three issues were “sovereign rights” and “non-negotiable” in the deal Dutton ...

A commercial site of 0.84 acre in Sector 68 behind the National Institute of Pharmaceutical Education and Research (NIPER) ...

On March 14, during the Holi celebration, a fire incident took place. Amid this, a huge amount of unaccounted cash was ...

We recently published a list of Was Jim Cramer Right About These 23 Stocks?. In this article, we are going to take a look at ...

Chennai: Central Bureau of Investigation (CBI) has taken over investigation of a 6 crore cheating case related to the export ...

Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines.